Greenstone Partners Closes Sale of 225K-SF Lake Forest Office Complex

Why It Matters

The deal highlights sustained investor appetite for suburban office assets that offer value‑add lease‑up opportunities, signaling confidence in the region’s corporate real‑estate demand.

Key Takeaways

• Sale price $8.9 million for 225k‑sf office complex.
• 15 qualified bidders participated in competitive auction.
• Property only 43% leased, offering significant upside.
• Major tenants have leases through 2030 and beyond.
• Near AbbVie, Pfizer, Brunswick, CDW, Grainger campuses.

Pulse Analysis

The sale of Conway Park underscores a broader trend of investors targeting suburban office parks that combine strategic location with under‑leased space. Greenstone Partners orchestrated a robust auction, drawing fifteen qualified bidders—a clear indicator that capital is actively seeking assets with upside potential. The $8.9 million price tag reflects both the current market valuation and the perceived opportunity to enhance occupancy through targeted leasing strategies.

Leasing dynamics are central to the asset’s appeal. At only 43% occupancy, the complex offers a sizable pipeline for lease‑up, especially given its efficient floor plates and smaller suite configurations that align with modern tenant preferences for flexibility. Three of the five largest tenants have contracts extending beyond 2030, providing a stable cash flow foundation while the remaining space can be marketed to nearby life‑science and technology firms that gravitate toward the region’s corporate hubs.

For the broader commercial‑real‑estate landscape, this transaction signals confidence in the Lake Forest sub‑market, which benefits from proximity to industry giants like AbbVie, Pfizer, and Grainger. Investors such as The STG Group see value in acquiring assets that can be repositioned through active lease‑up and operational improvements. As companies continue to balance remote work with the need for collaborative spaces, well‑located, under‑leased office complexes are likely to remain attractive targets for value‑oriented capital.